ESTRO 2024 - Abstract Book

S609

Clinical - Breast

ESTRO 2024

activation in terms of toxicities. In this regard, our analysis represents a starting point for future efficacy and safety real world evaluations of adjuvant radio-immunotherapy combination in patients with early triple negative breast cancer.

Keywords: Radioimmunotherapy, Feasibility